Furthermore, miR-200c represses ribosomal protein S6 kinase B1 (S6K1), a key downstream effector of the mTOR pathway [99], thereby linking it to dysregulated translational control and synaptic dysfunction, which are relevant to CDD. Here, RPS6KB1 is linked to craniodiaphyseal dysplasia.